Learn More
Caspase-3 Antibody (31A1067) - (Pro and Active) - BSA Free, Novus Biologicals™
Shop All R&D Systems Products

Description
Specifications
Specifications
| Antigen | Caspase-3 |
| Applications | Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), Immunoblot, Immunoassay, Immunohistochemistry (Free Floating), CyTOF |
| Classification | Monoclonal |
| Clone | 31A1067 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Dilution | Western Blot 1 - 5 ug/ml, Simple Western 1:50, Flow Cytometry reported in scientific literature (PMID 27429862), Immunohistochemistry 1:10 - 1:500, Immunocytochemistry/Immunofluorescence reported in scientific literature (PMID 23840553), Immunohistochemistry-Paraffin 1:10 - 1:500. Use reported in scientific literature (PMID 28500555), Immunohistochemistry-Frozen 1:10 - 1:500. Use reported by customer review, Immunoblotting reported in scientific literature (PMID 28500555), Hematoxylin and Eosin Stain reported in scientific literature (PMID 28186963), Electron Microscopy reported in scientific literature (PMID 27450722), Immunohistochemistry Free-Floating reported in scientific literature (PMID 31771656), CyTOF-ready, Knockout Validated, KnockDown Validated reported in scientific literature (PMID 32867814) |
| Gene Accession No. | P42574 |
| Gene Alias | Apopain, apoptosis-related cysteine protease, CASP-3, caspase 3, apoptosis-related cysteine peptidase, caspase-3, CPP-32, CPP32B, CPP32SREBP cleavage activity 1, Cysteine protease CPP32, EC 3.4.22, EC 3.4.22.56, PARP cleavage protease, procaspase3, Protein Yama, SCA-1, Yama |
| Gene Symbols | CASP3 |
| Show More |
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.